Internal Medicine, Endocrinology, Diabetes, & Metabolism · West Hills, CA
NPI
1902817901
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
7345 Medical Center Dr, Suite 600
West Hills, CA, 91307
Phone (818) 347-2921
Groups this clinician bills Medicare through
Medicare paid, 2024
$232K
15,973 services
Medicare patients, 2024
401
Average age 75
Drug cost, 2024
$3.2M
10,670 prescriptions
Company payments, 2025
$7,794
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David B Fittingoff was code J0897 (injection, denosumab, 1 mg), 4,860 times for 47 patients. In total David B Fittingoff billed 15,973 services in 31 codes, and Medicare paid $232K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 4,860 | 47 | $20.46 | $99K |
| 99214 Office E&M - Established | Office | 666 | 266 | $100.72 | $67K |
| 99213 Office E&M - Established | Office | 275 | 159 | $71.30 | $20K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 225 | 168 | $13.71 | $3,084 |
| 95251 Test - Miscellaneous | Office | 221 | 90 | $27.82 | $6,148 |
| 96372 Injection Administration | Office | 130 | 57 | $12.42 | $1,615 |
| 99204 Office E&M - New | Office | 46 | 46 | $119.25 | $5,486 |
| 77080 Standard X-ray | Office | 39 | 39 | $44.42 | $1,732 |
| 82962 Clinical Chemistry | Office | 27 | 18 | $3.21 | $86.67 |
| 76536 Ultrasound - Nonspecific | Office | 13 | 12 | $84.40 | $1,097 |
| G0008 Administration of influenza virus vaccine | Office | 13 | 12 | $35.02 | $455 |
| 93000 Electrocardiogram | Office | 11 | 11 | $12.22 | $134 |
By year: 2022 $177K for 20,173 services; 2023 $187K for 14,323 services; 2024 $232K for 15,973 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 27 | 18 | $3.21 | $86.67 |
Medicare prescription drug claims, 2024
In 2024, the drug David B Fittingoff prescribed most often to Medicare patients was Atorvastatin Calcium, with 756 prescriptions and refills. In total David B Fittingoff wrote 10,670 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 756 | 2,142 | 229 | $8,321 |
| Metformin Hcl Generic | 566 | 1,582 | 167 | $4,788 |
| Levothyroxine Sodium Generic | 516 | 1,476 | 152 | $6,641 |
| Ozempic Semaglutide | 488 | 893 | 111 | $851K |
| Amlodipine Besylate Generic | 350 | 950 | 105 | $2,377 |
| Jardiance Empagliflozin | 275 | 650 | 83 | $366K |
| Lisinopril Generic | 238 | 682 | 74 | $2,289 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 219 | 517 | 77 | $26K |
| Alprazolam Generic | 200 | 206 | 30 | $765 |
| Rosuvastatin Calcium Generic | 164 | 498 | 56 | $2,418 |
| Ezetimibe Generic | 164 | 429 | 42 | $3,389 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 163 | 166 | 24 | $2,484 |
| Humalog Kwikpen U-100 Insulin Lispro | 151 | 332 | 44 | $39K |
| Farxiga Dapagliflozin Propanediol | 151 | 337 | 40 | $181K |
| Zolpidem Tartrate Generic | 135 | 164 | 29 | $706 |
Brand drugs: 3,029 claims; generic drugs: 7,239 claims; opioid claims: 319.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David B Fittingoff $7,794 ($7,794 in general payments such as food, travel and fees) from 27 companies. The largest payer was Amgen Inc. with $1,311.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 24 | $1,311 |
| Dexcom, Inc. DXCM | 23 | $1,082 |
| Novo Nordisk Inc NVO | 34 | $847 |
| Xeris Pharmaceuticals, Inc. | 30 | $656 |
| Abbott Laboratories ABT | 20 | $637 |
| Corcept Therapeutics CORT | 18 | $454 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $427 |
| Mannkind Corporation MNKD | 4 | $379 |
| Madrigal Pharmaceuticals MDGL | 9 | $258 |
| Ascendis Pharma Endocrinology Inc ASND | 5 | $229 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.